Brokers Offer Predictions for Aurora Cannabis Q1 Earnings

Aurora Cannabis Inc. (TSE:ACB) – Equities researchers at Roth Capital issued their Q1 2026 EPS estimates for shares of Aurora Cannabis in a research report issued to clients and investors on Thursday, February 6th. Roth Capital analyst W. Kirk anticipates that the company will post earnings of $0.24 per share for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2026 earnings at $0.03 EPS, Q3 2026 earnings at $0.57 EPS and Q4 2026 earnings at $0.41 EPS.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported C$0.05 EPS for the quarter, topping analysts’ consensus estimates of C($0.30) by C$0.35. Aurora Cannabis had a negative net margin of 11.53% and a negative return on equity of 6.13%. During the same period in the prior year, the business earned ($0.70) earnings per share.

Other equities analysts have also issued research reports about the company. TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. ATB Capital lowered their target price on shares of Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Aurora Cannabis has a consensus rating of “Moderate Buy” and an average price target of C$5.85.

Aurora Cannabis Trading Up 17.1 %

ACB opened at C$8.96 on Friday. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The firm has a market cap of C$489.75 million, a price-to-earnings ratio of -14.22 and a beta of 2.71. Aurora Cannabis has a 12 month low of C$3.84 and a 12 month high of C$12.85. The stock has a fifty day moving average price of C$6.03 and a 200-day moving average price of C$7.17.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.